Field Trial Success Drives Advancement in Asian Soybean Rust Resistance

Jul 20, 2022

2Blades and Corteva Agriscience Reach Collaboration Milestone in Development of Durable Resistance for Latin American Soybean Varieties

EVANSTON, Ill., and INDIANAPOLIS, July 20, 2022 /PRNewswire/ -- Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene. This achievement marks an important point in the research collaboration between the two organizations, which seeks to develop durable resistance and minimize grower losses due to the plant pathogen.

Endemic to most soybean-producing regions of the globe, ASR can cause yield loss ranging from 10-80% in countries where it is established, carrying significant risk for farmers and agricultural systems. Soybeans in Latin America are particularly vulnerable to this fungal disease due to mild winter conditions, which allow the fungus to survive year-round. The transgenic trait in development by 2Blades and Corteva will provide an additional disease management tool for farmers in the region, increasing disease resistance durability and options for integrated disease management strategies.

"Results from the trial showed strong disease resistance in the transgenic soybean varieties tested," said Dr. Tom Greene, Biotechnology Leader at Corteva Agriscience. "Our partnership with 2Blades combines the strengths of our organizations in pursuit of our common goal: enhancing the productivity of soybeans for farmers across Latin America via stronger plant genetics."

2Blades' knowledge of disease resistance, combined with Corteva's laboratory and field testing proficiency, as well as product development expertise, prompted the initial decision to collaborate in 2013. From 2013 to 2018, 2Blades and Corteva undertook joint research to identify novel ASR resistance genes at the Universidade Federal de Viçosa in Minas Gerais, Brazil, and at the 2Blades Group located within The Sainsbury Laboratory in Norwich, UK. Additional testing has been conducted across Corteva's global research footprint.

"Lead genes from our collaboration continue to advance in our pipeline, allowing us to better understand their performance against key ASR pathogens that impact our growers in Latin America," said Dr. Jeff Habben, who leads the Disease Resistance Discovery group at Corteva Agriscience. "Reaching this collaborative milestone reinforces our trajectory and builds confidence in our approach."

While scientific advancements have led to some improvements in soybean rust control in countries such as Brazil, durable genetic resistance is an important tool for farmers to mitigate the risk of the disease.

"Soybean rust is a key challenge for growers and needs to be combatted with an integrated strategy," said Dr. Peter van Esse, Vice President and Group Leader at 2Blades. "Genetic resistance against this disease will help give growers a powerful tool to manage the disease in a more effective and sustainable way." 

About 2Blades
2Blades ( is a 501(c)3 not-for-profit ag-biotech organization dedicated to developing durable disease resistance in agricultural crops.

About Corteva Agriscience  
Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovations, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at

Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube

™ ®  Trademarks and service marks of Corteva Agriscience and its affiliated companies.

Cision View original content to download multimedia:

SOURCE Corteva, Inc.

Mike Kelleher, 2Blades, 312-823-4976,; Larissa Capriotti, Corteva Agriscience, +55 (11) 9 9358-4006,

Contact Us

For additional information on Corteva Agriscience:


Investor Email Alerts

Search Investor Relations

Safe Harbor Regarding Forward Looking Statements

The information provided herein contains certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates goals” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward-looking statements. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement environmental, sustainability, and governance goals or targets or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K